OpenAI’s recent $11 billion funding tranche at a $1.25 trillion pre-money valuation, following a downward revision from earlier $1.4 trillion targets amid AI stock volatility, anchors trader expectations for any 2027 debut while highlighting execution risks. Executives including CFO Sarah Friar and President Greg Brockman reaffirmed a 2027 IPO timeline after the June 2026 confidential S-1 filing, citing AI safety priorities and strong enterprise revenue growth that now comprises the majority of sales. Rival Anthropic’s imminent Nasdaq listing supplies a key valuation benchmark, with broader market conditions and infrastructure spending needs adding uncertainty to both timing and final market capitalization.